Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia

NCT04355026 is registered in ClinicalTrials.gov with General and Teaching Hospital Celje as lead sponsor.

NCT NCT04355026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04355026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia
Lead sponsor
General and Teaching Hospital Celje
Phase
Phase 4
Overall status
Unknown status
Start date
April 10, 2020
Completion date
July 31, 2020
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19